[Intravenous infusion of molsidomine in infarct therapy]. 1994

B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
Krankenanstalten Düren, Akademisches Lehrkankenhaus, RWTH Aachen.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008981 Molsidomine A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS. Morsydomine,Corpea,Corvaton,Duracoron,Fali-Cor,Korvatone,MTW-Molsidomin,Molsi 1A Pharma,Molsi-AZU,Molsi-Puren,Molsibeta,Molsicor,Molsidain,Molsidomin,Molsidomin Heumann,Molsidomin Stada,Molsidomin Von Ct,Molsidomin-Ratiopharm,Molsihexal,Molsiket,SIN-10,Sydnopharm,Fali Cor,Heumann, Molsidomin,MTW Molsidomin,Molsi AZU,Molsi Puren,Molsidomin Ratiopharm,SIN 10,SIN10,Von Ct, Molsidomin
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005080 Exercise Test Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used. Arm Ergometry Test,Bicycle Ergometry Test,Cardiopulmonary Exercise Testing,Exercise Testing,Step Test,Stress Test,Treadmill Test,Cardiopulmonary Exercise Test,EuroFit Tests,Eurofit Test Battery,European Fitness Testing Battery,Fitness Testing,Physical Fitness Testing,Arm Ergometry Tests,Bicycle Ergometry Tests,Cardiopulmonary Exercise Tests,Ergometry Test, Arm,Ergometry Test, Bicycle,Ergometry Tests, Arm,Ergometry Tests, Bicycle,EuroFit Test,Eurofit Test Batteries,Exercise Test, Cardiopulmonary,Exercise Testing, Cardiopulmonary,Exercise Tests,Exercise Tests, Cardiopulmonary,Fitness Testing, Physical,Fitness Testings,Step Tests,Stress Tests,Test Battery, Eurofit,Test, Arm Ergometry,Test, Bicycle Ergometry,Test, Cardiopulmonary Exercise,Test, EuroFit,Test, Exercise,Test, Step,Test, Stress,Test, Treadmill,Testing, Cardiopulmonary Exercise,Testing, Exercise,Testing, Fitness,Testing, Physical Fitness,Tests, Arm Ergometry,Tests, Bicycle Ergometry,Tests, Cardiopulmonary Exercise,Tests, EuroFit,Tests, Exercise,Tests, Step,Tests, Stress,Tests, Treadmill,Treadmill Tests
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
July 1994, Medizinische Klinik (Munich, Germany : 1983),
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
January 1991, Zeitschrift fur Kardiologie,
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
July 1994, Medizinische Klinik (Munich, Germany : 1983),
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
July 1994, Medizinische Klinik (Munich, Germany : 1983),
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
October 1978, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
December 1982, Naunyn-Schmiedeberg's archives of pharmacology,
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
July 1994, Medizinische Klinik (Munich, Germany : 1983),
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
January 1984, Zeitschrift fur Kardiologie,
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
September 1992, The American journal of cardiology,
B Zentgraf, and A Costard-Jäckle, and M Fuchs, and K Funke, and G Kreymann, and J Lessmann, and F G Nowak, and H R Milstrey, and E G Schmidt, and H Simon
May 1993, The Journal of pharmacy and pharmacology,
Copied contents to your clipboard!